Get started
Author

Antonio Asensi Cantó

Observed names: A Asensi Cantó, A. Asensi Cantó, Antonio Asensi Canto, Antonio Asensi-Cantó
ORCID: 0000-0002-2705-2682
Observed ORCID: 0000-0002-2705-2682
OpenAlex ID: A5100496183
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
2022 · Antonio Asensi-Cantó, María Dolores López-Abellán, et al. · Cancers · 33
PDF
Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial
2023 · Antonio Asensi-Cantó, Edith Rodríguez-Braun, et al. · Frontiers in Oncology · 13
PDF
Distribution of the J1 haplotype variant rs2267439 across CYP2D6 diplotypes and its impact on risperidone metabolism
2026 · Antonio Asensi Canto, Wendy Y. Wang, et al. · Pharmacogenetics and Genomics
117eP Imipramine-induced transcriptomic reprogramming in breast cancer: A comparative analysis in luminal and triple-negative cell lines
2026 · A. Izquierdo Martínez, A. Beltrán-Videla, et al. · ESMO Open
361eTiP HITCLIF. histological and clinical effects of imipramine in the treatment of patients with cancer over expressing fascin1
2026 · A. Beltrán-Videla, A. Asensi Cantó, et al. · ESMO Open
PDF
3PC-004 Implementation of an aseptic technique validation protocol in a pharmacy department
2025 · IJ Tamboleo Sánchez, J Fernández Vela, et al. · European Journal of Hospital Pharmacy
PDF
Diseño y validación galénica de una formulación de morfina gel al 1% para el tratamiento de úlceras dolorosas
2024 · María Encarna Martínez Madrid, Amelia María Chica Marchal, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
Works count: 7
Citation count: 46
H-index: 2
I10-index: 2
Year
Topic
Type